Events

COSENTYX® (secukinumab) prescribing information (external link)

This page includes promotional meetings and events organised and funded by Novartis Pharmaceuticals UK Ltd. Novartis products may be mentioned on this page and/or subsequent event pages.

 Rheumatology

COSENTYX® (secukinumab)

Image of people partaking in a range of activities with the text 'See the possibility of sustained remission…Help your eligible patients feel relief from the daily burden of disease'.
Apr 29
Event
Crowne Plaza Hotel,
April 29, 2026 19:15
The Potential for Remission in PsA and a Debate on Skin Symptoms in Treatment Decision-Making
Event
Crowne Plaza Hotel,
29.04.2026
The Potential for Remission in PsA and a Debate on Skin Symptoms in Treatment Decision-Making
Crowne Plaza Hotel,
Novartis UK
19:15 Hrs - 21:30 Hrs

This promotional event has been organised and funded by Novartis Pharmaceuticals UK Ltd.
 

UK | January 2026 | FA-11538677-1

See more details
Hide details
Image of people partaking in a range of activities with the text 'See the possibility of sustained remission…Help your eligible patients feel relief from the daily burden of disease'.
Jun 04
Event
London City Hall
June 4, 2026 18:45
Psoriatic Disease in the Spotlight
Event
London City Hall
04.06.2026
Psoriatic Disease in the Spotlight
London City Hall
Novartis Immunology UK
18:45 Hrs - 21:15 Hrs

This promotional event has been organised and funded by Novartis Pharmaceuticals UK Ltd.

UK | April 2026 | FA-11615523

See more details
Hide details

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.